{"id":498,"date":"2010-07-07T20:25:00","date_gmt":"2010-07-08T00:25:00","guid":{"rendered":"https:\/\/med.sites.unc.edu\/cfpulmcenter\/core-facilities\/clinicaltranslationalcore\/"},"modified":"2025-03-27T13:13:32","modified_gmt":"2025-03-27T17:13:32","slug":"clinicaltranslationalcore","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/core-facilities\/clinicaltranslationalcore\/","title":{"rendered":"CF Clinical Translational Core"},"content":{"rendered":"

<\/p>\n

<\/p>\n

<\/p>\n

Director: Scott H. Donaldson, MD<\/a><\/p>\n

\n

MISSION<\/strong><\/h2>\n

The development and validation of biomarkers that reflect different aspects of cystic fibrosis are of paramount importance to continued efforts to understand disease biology and the development of new therapeutics. Further, translation of basic research ideas into clinical studies that test their validity and clinical utility is of paramount importance to scientific advances in CF. The CF Clinical Translation Core was established to facilitate these goals.<\/p>\n

\"Photograph<\/p>\n

\"Photograph<\/p>\n

 <\/p>\n

SERVICES<\/strong><\/h2>\n